Lisa A. Carey

1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
   2020/01/13 by Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett +17 · 10 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Breast Lesions and Carcinomas #Estrogen and related hormone effects
2. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
   2021/01/28 by Larissa A. Korde, Mark R. Somerfield, Lisa A. Carey +16 · 3 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Breast Lesions and Carcinomas #HER2/EGFR in Cancer Research
3. Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR trial.
   2025/05/28 by Nadine Tung, Nadine M. Tung, Fengmin Zhao +24 · 1 citation
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #HER2/EGFR in Cancer Research #Lung Cancer Treatments and Mutations